ArticleDiagnostics (Basel, Switzerland)2020

Ki67 and PR in Patients Treated with CDK4/6 Inhibitors: A Real-World Experience.

Michela Palleschi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.